Skip to Content
MilliporeSigma

Antimicrobial susceptibilities of clinical isolates of HACEK organisms.

Antimicrobial agents and chemotherapy (2013-02-14)
Bryan Coburn, Baldwin Toye, Prasad Rawte, Frances B Jamieson, David J Farrell, Samir N Patel
ABSTRACT

The "HACEK" organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinical HACEK isolates to 18 antimicrobials. All isolates were susceptible to ceftriaxone and levofloxacin, indicating that these agents remain appropriate empirical choices for the treatment of infections with this group of organisms.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Ceftriaxone disodium salt hemi(heptahydrate), third-generation cephalosporin antibiotic
Pricing and availability is not currently available.
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Pricing and availability is not currently available.
Supelco
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Pricing and availability is not currently available.
Ceftriaxone sodium, European Pharmacopoeia (EP) Reference Standard
Pricing and availability is not currently available.
Supelco
Ofloxacin, VETRANAL®, analytical standard
Pricing and availability is not currently available.
Supelco
Levofloxacin, analytical standard
Pricing and availability is not currently available.